Pricing Log in Create free account
Saturday 7 November 2026 Export HITI’s income statement to Excel — free account

High Tide Inc.

HITI Healthcare Pharmaceutical Retailers

High Tide Inc.’s revenue for fiscal 2025 (year ended October 2025) was $424.0 million, up 10.5% from fiscal 2024.

Revenue
+30.7%
EPS
+800.0%
Free cash flow
−7.91%
Total debt
+54.7%

Quarter to July 2026, against a year earlier

2.63 0.00 0.00%
Market cap
$234.4M
P/E
0.0×
Fwd P/E
23.4×
Dividend yield
—
F-score
2/9
Altman Z
1.52
Beneish M
−3.01
Dividend safety
25/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 11.71%

Capital & Financial Ratios $m

Size
Market Cap 234.44
Revenue ttm 519.66
Net income ttm (24.39)
Free cash flow ttm 11.14
Net debt Q 45.73
Valuation
P/E 0.00
Forward P/E 23.40
Price / sales 0.45
Forward P/S Powerpack
Price / FCF 20.84
Price / book 2.70
Financial health
Current ratio Q 1.50
Debt / equity Q 0.93
Interest coverage Q 1.56
Growth
Revenue growth Q +30.72% (above 0%: growing)
Operating income growth Q +129.26% (above 0%: growing)
EPS, this year +127.19% (at or above 15%: strong)
EPS, next year A +10.36%
Revenue, next year A +27.58% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A —

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.5×, against a ten-year median of 0.5×; over the ten years it ranged from 0.4× in 2023 to 55.0× in 2021.
P/S against its own 10 years 39.47%
10-year low 10-year high
P/B against its own 10 years 62.13%
10-year low 10-year high
EV/Sales against its own 10 years 47.21%
10-year low 10-year high
EV/FCF against its own 10 years 80.06%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 22 35 34 34
Receivables 6 2 4 7
Inventory 19 22 48 48
Other — — — —
51 63 98 105
2023 2024 2025 Q'26
Payables 15 17 34 38
ST’ Debt 18 9 12 10
Other 3 — 7 3
43 45 71 70

Compound Annual Growth %

10y 5y 3y
Sales — 46.92% 15.22%
Cash Flow — 20.95% 69.61%
Earnings — 0.00% 0.00%
Book Value — 53.11% (16.46%)

Earnings Trends EPS, adjusted, against the consensus

Jul 2026 Estimate 0.01 Actual 0.02

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Oct 2025 0.00 0.01 Beat by 0.01
Jan 2026 0.00 0.01 Beat by 0.01
Apr 2026 −0.02 0.01 Beat by 0.03
Jul 2026 0.01 0.02 Beat by 0.01
Oct 2026 0.01 — Reports 4 February 2027

EPS $

Jan Apr Jul Oct Year
’26 0.01 0.00 0.09 — —
’25 (0.02) (0.03) 0.01 (0.42) (0.44)
’24 0.00 0.00 0.01 (0.04) (0.04)
’23 (0.04) (0.02) (0.03) (0.29) (0.39)
’22 (0.11) (0.11) (0.03) (0.64) (0.89)
’21 (0.02) (0.02) (0.03) (0.07) (0.67)
’20 (0.02) (0.02) 0.01 (0.11) (0.02)
Fiscal quarters ending in the months shown.

Revenue $m

Jan Apr Jul Oct Year
’26 129 131 142 — —
’25 100 97 109 118 424
’24 95 92 96 101 384
’23 88 89 93 92 362
’22 57 64 74 82 277
’21 30 32 39 43 144
’20 10 14 17 20 62
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Jan Apr Jul Oct Year
’26 4 3 7 — —
’25 0 6 8 3 17
’24 5 9 4 7 26
’23 2 1 6 7 15
’22 (1) (2) 0 6 3
’21 1 (3) (4) 4 (2)
’20 0 2 4 1 7
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Jan Apr Jul Oct Year
’26 3 2 6 — —
’25 (1) 4 6 1 10
’24 4 8 2 6 20
’23 0 0 5 5 11
’22 (3) (4) (2) 6 (4)
’21 0 (5) (4) 1 (9)
’20 0 2 3 1 5
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to October

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jul ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — 8 7 24 62 144 277 362 384 424 520 +64.9% 541 598 637 +14.5%
Gross margin, % — 46.83 0.98 36.16 37.00 35.33 28.29 26.93 27.28 25.85 26.10 (21.0) pt
EBT — 0 (5) (20) (5) (28) (57) (36) (3) (37) (24) n/m
EBT margin, % — 5.62 (68.90) (86.28) (7.36) (19.75) (20.67) (9.96) (0.84) (8.66) (4.71) (14.3) pt
Net income — 0 (3) (20) (5) (28) (55) (30) (3) (37) (24) n/m
Per share, $
Per share, $ Revenue — 0.62 0.53 0.12 0.27 3.39 4.42 4.86 4.82 5.16 5.91 +30.4%
Earnings — 0.02 (0.27) (0.10) (0.02) (0.67) (0.89) (0.39) (0.04) (0.44) (0.28) n/m
Cash flow — 0.06 (0.53) (0.06) 0.03 (0.05) 0.06 0.21 0.33 0.21 0.20 +15.8%
Capex — 0.00 0.00 (0.04) (0.01) (0.15) (0.11) (0.06) (0.08) (0.09) (0.07) n/m
Free cash flow — 0.06 (0.53) (0.10) 0.02 (0.21) (0.06) 0.15 0.25 0.12 0.13 +7.9%
Book value — (0.60) 1.42 0.04 0.04 2.85 2.01 1.33 1.34 0.89 0.98 n/m
Shares, m — 13 13 198 229 42 63 74 80 82 86 +26.5%
Valuation, ×
Valuation, × P/E — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0
P/S — 0.00 0.00 0.00 0.51 1.70 0.33 0.30 0.58 0.60 0.45 0.4
P/B — 79.07 79.07 79.07 4.08 2.03 0.73 1.09 2.10 3.48 2.70 27.9
EV/Sales — 0.00 0.00 0.00 0.99 1.86 0.43 0.37 0.59 0.69 0.53 0.5
EV/FCF — 0.00 0.00 0.00 8.58 (30.46) (33.98) 12.37 11.61 30.10 24.94 (0.2)
Cash, $m
Cash, $m Operating cash flow — 1 (7) (11) 7 (2) 3 15 26 17 17 +46.4%
Capex — 0 (3) (8) (2) (7) (7) (5) (7) (7) (6) +92.5%
Free cash flow — 1 (7) (19) 5 (9) (4) 11 20 10 11 +36.4%
Balance, $m
Balance, $m Working capital — (8) 11 1 (6) 4 3 8 18 26 35 n/m
Net debt — 13 (6) 15 26 23 29 26 3 36 46 +13.5%
Shareholders’ equity — (7) 18 7 9 121 126 99 107 73 86 n/m
Returns, %
Returns, % ROA — 1.62 (34.87) (78.43) (11.45) (22.49) (27.24) (15.08) (1.80) (16.85) (10.50) (18.5) pt
ROIC — 0.00 0.00 (42.85) 1.06 (5.50) (22.71) (15.36) 2.09 (5.89) (0.64) (5.9) pt
ROE — 4.45 (66.85) (158.98) (59.84) (43.00) (45.18) (25.91) (3.09) (40.19) (25.05) (44.6) pt
People
People Employees — — — — — 996 1,300 1,550 1,550 1,832 — +16.5%
Revenue/emp, $m — 0.00 0.00 0.00 0.00 0.14 0.21 0.23 0.25 0.23 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Oct 2025 · latest quarter Jul 2026 · fundamentals updated 25 Oct 2026

High Tide Inc. vs peers in Pharmaceutical Retailers (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
HITI High Tide Inc. $234.4M — (loss-making) 23.4× +30.72% (above 0%: growing) +800.00% (above 0%: growing) −7.91% (below 0%: shrinking) 26.53% 4.38%
PETS PetMed Express, Inc. $26.9M — (loss-making) — (loss-making) −19.86% (below 0%: shrinking) n/m +38.60% (above 0%: growing) 27.63% (15.19%) Compare
POM Pomdoctor Limited - Sponsored ADR $11.6M — — — — — — — Compare
SCNX Scienture Holdings, Inc. $5.1M — (loss-making) — (loss-making) +3,235.92% (above 0%: growing) n/m −53.98% (below 0%: shrinking) 97.73% (785.71%) Compare
RDGT Ridgetech Inc. $2.7M — (loss-making) — (loss-making) +113.14% (above 0%: growing) n/m +4,848.31% (above 0%: growing) 22.81% 0.00% Compare
Median of peers $8.3M — — +113.14% — +38.60% 27.63% (15.19%)

All 5 Pharmaceutical Retailers stocks →

High Tide Inc. (HITI) Latest News

28 Oct

Impact 4 · · MarketBeat

27 Oct

Impact 4 · · ACCESS Newswire

9 Oct

Impact 3 · · CNW Group
Impact 3 · · PR Newswire

1 Oct

Impact 3 · · CNW Group
Impact 3 · · PR Newswire

30 Sep

Impact 4 · · ACCESS Newswire

28 Sep

Impact 4 · · CNW Group
Impact 4 · · PR Newswire

22 Sep

Impact 3 · · PR Newswire
Impact 3 · · CNW Group

17 Sep

Impact 4 · · The Motley Fool transcript
Impact 3 ·

16 Sep

Impact 4 ·
Impact 4 ·
Impact 3 ·

15 Sep

Impact 3 · · MarketBeat
Impact 3 · · Moby transcript

14 Sep

Impact 4 ·
Impact 4 ·

31 Aug

Impact 3 · · CNW Group

11 Aug

Impact 3 ·

5 Aug

Impact 4 ·
Impact 4 ·

4 Aug

Impact 4 ·
Impact 3 ·

30 Jul

Impact 3 ·
Impact 3 ·

21 Jul

Impact 3 ·

6 Jul

Impact 3 ·
stockrow.com/HITI · Data as of Oct 25, 2026 · For information only; not investment advice. · © 2026 stockrow.com